XASXCAN
Market cap12mUSD
Jan 07, Last price
0.04AUD
1D
0.00%
1Q
-29.63%
IPO
-94.29%
Name
Cann Group Ltd
Chart & Performance
Profile
Cann Group Limited engages in the breeding, cultivation, production, manufacturing, clinical evaluation, and supplying medicinal cannabis for sale and use within Australia and for overseas export markets. It licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. The company was founded in 2014 and is based in Port Melbourne, Australia.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | 2016‑06 | 2015‑06 | |
Income | ||||||||||
Revenues | 15,373 11.58% | 13,777 114.90% | 6,411 49.34% | |||||||
Cost of revenue | 43,373 | 30,785 | 24,587 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (28,000) | (17,008) | (18,176) | |||||||
NOPBT Margin | ||||||||||
Operating Taxes | (5,955) | (4,520) | ||||||||
Tax Rate | ||||||||||
NOPAT | (28,000) | (11,053) | (13,656) | |||||||
Net income | (51,242) 51.65% | (33,790) 27.66% | (26,468) 5.44% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 4,457 | 7,915 | 17,921 | |||||||
BB yield | -35.07% | -17.72% | -19.29% | |||||||
Debt | ||||||||||
Debt current | 72,045 | 12,384 | 3,804 | |||||||
Long-term debt | 972 | 45,839 | 43,665 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 184 | 135 | 99 | |||||||
Net debt | 71,346 | 56,805 | 44,812 | |||||||
Cash flow | ||||||||||
Cash from operating activities | (15,185) | (22,835) | (20,433) | |||||||
CAPEX | (2,505) | (3,101) | (45,164) | |||||||
Cash from investing activities | 1,175 | (28) | (45,164) | |||||||
Cash from financing activities | 14,771 | 21,714 | 64,406 | |||||||
FCF | 5,864 | (1,818) | (55,439) | |||||||
Balance | ||||||||||
Cash | 1,640 | 765 | 1,914 | |||||||
Long term investments | 31 | 653 | 743 | |||||||
Excess cash | 902 | 729 | 2,336 | |||||||
Stockholders' equity | 13,921 | 59,261 | 84,903 | |||||||
Invested Capital | 85,669 | 119,632 | 129,831 | |||||||
ROIC | ||||||||||
ROCE | ||||||||||
EV | ||||||||||
Common stock shares outstanding | 453,859 | 372,252 | 337,793 | |||||||
Price | 0.03 -76.67% | 0.12 -56.36% | 0.28 -19.12% | |||||||
Market cap | 12,708 -71.55% | 44,670 -51.91% | 92,893 5.30% | |||||||
EV | 84,054 | 101,475 | 137,705 | |||||||
EBITDA | (16,963) | (5,048) | (13,379) | |||||||
EV/EBITDA | ||||||||||
Interest | 6,819 | 3,158 | 1,828 | |||||||
Interest/NOPBT |